ELK3 and central nervous system cancer: In our evaluation of whether synergistic effects occur between abnormally high expression levels of ELK3 and clinical features related to the prognosis of gliomas, the results suggested that ELK3 expression was closely related to age, WHO grade, recurrence status, 1p/19q codeletion status, IDH mutation status, and other clinical characteristics of patients with gliomas.